What is seqWell?
SeqWell, headquartered in Beverly, Massachusetts, is a global player in the life sciences sector, specializing in the development and provision of cutting-edge NGS library construction technologies. The company's proprietary plexWell technology is engineered to streamline the sample preparation process, offering unprecedented throughput, quality, and utility across various NGS platforms. By simplifying and scaling sample preparation, SeqWell empowers researchers and diagnostic labs to accelerate their genomic analyses and redefine industry standards in molecular biology.
How much funding has seqWell raised?
seqWell has raised a total of $17.4M across 4 funding rounds:
Private Equity
$1.3M
Series B
$9M
Debt
$150K
Series C
$7M
Private Equity (2016): $1.3M, investors not publicly disclosed
Series B (2020): $9M led by Research and BroadOak Fund
Debt (2020): $150K supported by PPP
Series C (2022): $7M featuring Research, Codexis, and BroadOak Capital Partners
Key Investors in seqWell
Research
Research Corp is a company operating in the Research & Development industry, known for its contributions to scientific advancement. Its investment in SeqWell suggests a focus on supporting innovative technologies within the life sciences sector.
Codexis
Codexis, Inc. is a leading enzyme engineering company that leverages its proprietary CodeEvolver platform for developing high-performance enzymes. Their investment indicates a strategic interest in SeqWell's technology, potentially for applications in biotherapeutics manufacturing or diagnostics.
BroadOak Capital Partners
BroadOak Capital Partners is a financial institution specializing in direct investment and banking services for life sciences and biopharma services companies. Their backing of SeqWell highlights their commitment to supporting growth-stage companies in the life sciences tools and diagnostics space.
What's next for seqWell?
With the recent strategic investment and substantial overall capital, SeqWell is poised for accelerated growth and further innovation in the NGS library preparation market. The company is likely to focus on expanding its technological capabilities, enhancing its product offerings, and broadening its market reach. This strategic financing will enable SeqWell to further its mission of engineering superior library preparation solutions and streamlined application workflows, solidifying its position as a leader in the rapidly evolving field of genomics.
See full seqWell company page
